According to Amit Aggarwal, Secretary, Department of Pharmaceuticals, the government has increased the expenditure on manufacturing incentives, infrastructure and ecosystem development by 44 per cent. He added that added that the government is also aiming to boost domestic manufacturing of important drugs under the PLI.